PT  - JOURNAL ARTICLE
AU  - Tabata, Yoshiteru
AU  - Matsuo, Yoshiyuki
AU  - Fujii, Yosuke
AU  - Ohta, Atsufumi
AU  - Hirota, Kiichi
TI  - Rapid detection of single nucleotide polymorphisms using the MinION nanopore sequencer: a feasibility study for perioperative precision medicine
AID  - 10.1101/2022.01.13.22269267
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.13.22269267
4099  - http://medrxiv.org/content/early/2022/01/14/2022.01.13.22269267.short
4100  - http://medrxiv.org/content/early/2022/01/14/2022.01.13.22269267.full
AB  - Introduction Precision medicine is a phrase used to describe personalized medical care tailored to specific patients based on their clinical presentation and genetic makeup. However, despite the fact that several single nucleotide polymorphisms (SNPs) have been reported to be associated with increased susceptibility to particular anesthetic agents and the occurrence of perioperative complications, genomic profiling and thus precision medicine has not been widely applied in perioperative management.Methods We validated six SNP loci known to affect perioperative outcomes in Japanese patients using genomic DNA from saliva specimens and nanopore sequencing of each SNP loci to facilitate allele frequency calculations and then compared the nanopore results to those produced using the conventional dideoxy sequencing method.Results Nanopore sequencing reads clustered into the expected genotypes in both homozygous and heterozygous cases. In addition, the nanopore sequencing results were consistent with those obtained using conventional dideoxy sequencing and the workflow provided reliable allele frequency estimation, with a total analysis time of less than 4 h.Conclusion Thus, our results suggest that nanopore sequencing may be a promising and versatile tool for SNP genotyping, allowing for rapid and feasible risk prediction of perioperative outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the branding program as a world-leading research university on intractable immune and allergic diseases supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, a research grant from the Kansai Medical University (KMU) research consortium to KH and YM, and research grant E from Kansai Medical University to YT. These funding bodies had no role in the design of the study, collection, analysis, interpretation of the data, or manuscript preparation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Review Board at Kansai Medical University Hospital (No. 2020285, February 19, 2021).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this study is available from the corresponding author upon reasonable request.NGSnext-generation sequencingPCRpolymerase chain reactionSNPsingle nucleotide polymorphismSNVsingle nucleotide variation